ImmunityBio's recently approved cancer drug has plenty of momentum. However, valuation concerns and clinical and regulatory ...
Karthik Sankaranarayanan trained in two quite different scientific subfields as a graduate student and as a postdoctoral ...
We recently published a list of 10 Hot Biotech Stocks Under $5. In this article, we are going to take a look at where aTyr Pharma, Inc. (NASDAQ:ATYR) stands against other hot biotech stocks under $5.
Hosted on MSN
Biotech and Pharma Market Update: Q3 2025 in Review
The third quarter was a pivotal period for both the biotech and pharmaceutical sectors, with regulatory developments and an increase in business deals shaping the landscape for the industries. Public ...
Good morning, and welcome once again to TD Cowen's 46th Annual Healthcare Conference. I'm Phil Nadeau, one of the biotech analysts here at Cowen, and it's my pleasure to do a fireside chat with ...
TrialAssure announced today announced the launch of its AI in Medical Writing Certification (AIMWC) Program, a new ...
Gilead has penned a potential $1.5 billion synthetic lethality deal with a Chinese biotech. A cell therapy company could end a one-year-plus biotech IPO drought in Tokyo. | Gilead penned a potential ...
As the pharmaceutical industry continues to evolve in the wake of pandemic-driven disruptions and heightened regulatory scrutiny, the role of the top pharmaceutical API manufacturer has taken on ...
When MEI Pharma announced it was considering its “strategic alternatives” in the wake of a failed merger last year, the options seemed pretty mundane. But, rather than winding down the company as the ...
The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Teva Pharmaceutical Industries wasn’t one of them. The 10 stocks that ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results